slides · global inventory
Title
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 303,780
Current window 295,531-295,560
Pages 10,126
Rows per page 30
Component
295,531-295,560 of 303,780
01
Includes Taro and Citi logos.10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · 10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup
Deck Investment bank Beat · Problem1 hit
02
10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · 10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup
Deck Investment bank Beat · Problem1 hit
03
10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · 10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup
Deck Investment bank Beat · Problem1 hit
04
10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · 10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup
Deck Investment bank Beat · Problem1 hit
05
Includes a financial snapshot with valuation multiples and a product-level sales table.10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · 10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup
Deck Investment bank Beat · Problem1 hit
06
The chart uses a dual-axis approach to show price (line) and volume (bars) with annotated callouts for specific events.10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · 10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup
Deck Investment bank Beat · Market Size1 hit
07
The slide highlights the lack of analyst coverage and low float (34%) resulting in low trading volume for Taro Pharma.10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · 10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup
Deck Investment bank Beat · Market Size1 hit
08
The slide uses a mix of historical (A) and estimated (E) data, with specific H1 comparisons.10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · 10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup
Deck Investment bank Beat · Market Size1 hit
09
The slide uses a combination of annual historical/forecast data and half-year comparisons to explain cost structure changes.10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · 10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup
Deck Investment bank Beat · Financials1 hit
10
Includes a detailed income statement table with Q1, Q2, H1 2012 actuals and 2012 estimates.10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · 10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup
Deck Investment bank Beat · Financials1 hit
11
10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · 10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup
Deck Investment bank Beat · Financials1 hit
12
Includes two bar charts showing historical/projected growth and a median benchmark line.10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · 10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup
Deck Investment bank Beat · FinancialsLoop · Pattern Hunter1 hit
13
Taro is highlighted in blue in each chart, while peers are in grey. Medians are indicated by red dashed lines.10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · 10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup
Deck Investment bank Beat · FinancialsLoop · Pattern Hunter1 hit
14
Includes specific footnotes regarding adjustments for peer data (e.g., Actavis, Paddock, Flomax).10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · 10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup
Deck Investment bank Beat · FinancialsLoop · Pattern Hunter1 hit
15
10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · 10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup
Deck Investment bank Beat · ValuationLoop · Golden Circle1 hit
16
Includes specific financial benchmarks like P/E ratios and valuation ranges relative to Sun Pharma's offer price.10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · 10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup
Deck Investment bank Beat · ValuationLoop · Golden Circle1 hit
17
Includes data on price bumps, offer premiums, and transaction duration.10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · 10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup
Deck Investment bank Beat · ValuationLoop · Golden Circle1 hit
18
Includes sensitivity tables for WACC vs Terminal EBITDA Multiple, WACC vs Implied Perpetuity Growth Rate, and WACC vs Terminal Value as a % of Enterprise Value.10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · 10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup
Deck Investment bank Beat · ValuationLoop · Golden Circle1 hit
19
The chart highlights a period of multiple uplift attributed to stock price appreciation ahead of product pricing increases.10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · 10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup
Deck Investment bank Beat · ValuationLoop · Golden Circle1 hit
20
Includes median lines for the full peer set and a sub-segment of sub-$5bn market cap peers.10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · 10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup
Deck Investment bank Beat · ValuationLoop · Golden Circle1 hit
21
10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · 10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup
Deck Investment bank 1 hit
22
Depreciation and amortization allocated 75%:25% between COGS and SG&A per Taro management.10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · 10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup
Deck Investment bank Loop · Cost Of Inaction1 hit
23
Includes mean and median calculations for the peer group and a sub-segment of peers under $5bn market cap.10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · 10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup
Deck Investment bank Loop · Cost Of Inaction1 hit
24
Includes a legend for healthcare deals and footnotes regarding data sources and methodology.10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · 10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup
Deck Investment bank Loop · Cost Of Inaction1 hit
25
Includes a legend for healthcare deals and a note about exclusions.10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · 10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup
Deck Investment bank Loop · Cost Of Inaction1 hit
26
Market data as of August 10, 2012. Cost of debt estimated based on current B rated high yield index.10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · 10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup
Deck Investment bank 1 hit
41
Data based on 13-F filings as of September 30, 2020.1 IBD presentation 2021 Fbl Financial Group Inc Barclays Capital · 1-ibd-presentation-2021-fbl-financial-group-inc-barclays-capital
Deck Investment bank Beat · Impact & Next Steps1 hit
42
1 IBD presentation 2021 Fbl Financial Group Inc Barclays Capital1 IBD presentation 2021 Fbl Financial Group Inc Barclays Capital · 1-ibd-presentation-2021-fbl-financial-group-inc-barclays-capital
Deck Investment bank Beat · Impact & Next Steps1 hit
43
Standard investment banking conflict of interest and relationship disclosure.1 IBD presentation 2021 Fbl Financial Group Inc Barclays Capital · 1-ibd-presentation-2021-fbl-financial-group-inc-barclays-capital
Deck Investment bank Beat · Impact & Next Steps1 hit
44
1 IBD presentation 2021 Fbl Financial Group Inc Barclays Capital1 IBD presentation 2021 Fbl Financial Group Inc Barclays Capital · 1-ibd-presentation-2021-fbl-financial-group-inc-barclays-capital
Deck Investment bank Beat · Impact & Next Steps1 hit